Target intelligence / Profile preview

Mucosal immune cell membrane

Molecular classification
Other
01

Overview

The mucosal immune cell membrane is the specialized lipid bilayer and protein complex of immune cells located in the mucosa-associated lymphoid tissue (MALT), including the gut, respiratory, and urogenital tracts (Nature Reviews Immunology, 2003). It serves as the primary interface for immune surveillance, facilitating the recognition of antigens and the regulation of local inflammatory responses (Journal of Clinical Investigation, 2014). This membrane is characterized by the expression of unique homing receptors, such as the alpha-4 beta-7 integrin and CCR9, which are essential for the site-specific migration of lymphocytes to mucosal tissues (New England Journal of Medicine, 2013). In autoimmune and inflammatory diseases like Crohn's disease and ulcerative colitis, the dysregulation of these membrane proteins leads to the pathological accumulation of inflammatory cells. Therapeutic agents, such as Vedolizumab, target specific proteins on this membrane to selectively inhibit leukocyte trafficking to the gut, thereby reducing inflammation while minimizing systemic immunosuppression (Gastroenterology, 2014). Understanding the molecular landscape of the mucosal immune cell membrane is vital for developing targeted therapies that maintain mucosal barrier integrity and treat chronic inflammatory conditions.

Other names
Mucosal lymphocyte membraneGut-associated lymphoid tissue (GALT) cell membraneMucosa-associated lymphoid tissue (MALT) cell membraneMucosal immune cell surface
02

Mechanism of action

Drugs targeting this site typically function as antagonists of membrane-bound adhesion molecules or chemokine receptors, thereby preventing the recruitment of pathogenic leukocytes into mucosal tissues (Nature Reviews Drug Discovery, 2018).

03

Biological functions

Immune responseCell-cell adhesionSignal transductionBarrier functionAntigen presentation
04

Disease associations

Inflammatory bowel diseaseCrohn's diseaseUlcerative colitisInfectionCeliac diseaseAllergy
05

Safety considerations

Increased risk of mucosal infectionsHypersensitivity reactionsPotential for Progressive Multifocal Leukoencephalopathy (PML) with certain integrin inhibitorsNasopharyngitis
06

Interacting drugs

Vedolizumab

4 more in the full profile.

07

Biomarkers

Alpha-4 beta-7 integrin expressionCCR9 expressionMAdCAM-1 expression

Beyond the preview

Go deeper on Mucosal immune cell membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucosal immune cell membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call